About Siponimod API
Therapeutic CategoryCentral Nervous System (CNS)
CAS Number
1230487-00-9
API Technology
Synthetic
Dose Form
Oral Solid/Tablets
Dr Reddy's Development Status
Available
Mechanism of Action
Siponimod is an oral, second generation sphingosine-1-phosphate receptor modulator. S1P receptor modulators can inhibit the egress and recirculation of lymphocytes from lymph nodes, a therapeutic strategy for treating certain autoimmune diseases
Indication
Secondary progressive multiple sclerosis
Related APIs
Eslicarbazepine Acetate
Central Nervous System (CNS)
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!